Pfizer Inc.
Chemical Compounds

Abstract:

The invention relates to benzimidazoles of Formula (I) ##STR00001## and pharmaceutically acceptable salts thereof, wherein R.sup.1 to R.sup.6 are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The benzimidazoles of Formula (I) are ITK inhibitors and are therefore potentially useful in the treatment of a wide range of disorders including, atopic dermatitis.